Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Health and Quality of Life Outcomes
Published in: Health and Quality of Life Outcomes 1/2021

Open Access 01-12-2021 | Stroke | Review

Effect of Buyang Huanwu decoction for the rehabilitation of ischemic stroke patients: a meta-analysis of randomized controlled trials

Authors: Li Gao, Zhuoran Xiao, Chunhua Jia, Wei Wang

Published in: Health and Quality of Life Outcomes | Issue 1/2021

Login to get access

Abstract

Purpose

Buyang Huanwu decoction (BHD) is a widely used traditional Chinese medicine for the rehabilitation of ischemic stroke patients in China, but its clinical efficacy and safety have not been adequately assessed. In this paper, we conducted a systematic review and meta-analysis to evaluate the efficacy and safety of BHD.

Methods

We searched seven electronic databases from inception to 31 March 2019. The language was limited to Chinese and English. Randomized controlled trials evaluating the efficacy and safety of BHD for the rehabilitation of ischemic stroke patients were included in the meta-analysis. Reviewers independently performed the screening, data extraction, bias assessment, and data analysis. The treatment efficacy was pooled in a meta-analysis using RevMan 5.3 software with a random-effect model. Any disagreement was resolved by discussion among all reviewers. The PRISMA statement was used in the review process.

Results

A total of 11 studies with 1084 patients were included in the meta-analysis. The results suggested that BHD was superior to other treatments in terms of clinical efficacy in symptoms and daily activities (n = 684, RR = 1.12, 95% CI: 0.99 to 1.27), clinical efficacy in TCM symptoms (n = 280, RR = 1.45, 95% CI: 1.03 to 2.03), National Institute of Health stroke scale (n = 192, MD = 1.66, 95% CI: -1.08 to 4.40), and activities of daily living (n = 200, MD = 8.20, 95% CI: -3.95 to 20.35).

Conclusions

The results supported the clinical use of BHD for the rehabilitation of ischemic stroke patients. However, the methodological qualities of the included studies were relatively low, and there were limited reports on adverse events. The clinical efficacy and safety of BHD need to be further confirmed by more well-designed and high-quality randomized controlled trials to warrant the clinical recommendation of BHD for the rehabilitation of ischemic stroke patients.
Appendix
Available only for authorised users
Literature
1.
Johnson CO, Nguyen M, Roth GA, Nichols E, Alam T, Abate D, et al. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):439–58.CrossRef
2.
Gittler M, Davis AM. Guidelines for Adult Stroke Rehabilitation and RecoveryGuidelines for Adult Stroke Rehabilitation and RecoveryGuidelines for Adult Stroke Rehabilitation and Recovery. JAMA. 2018;319(8):820–1.CrossRef
3.
Dewilde S, Annemans L, Lloyd A, Peeters A, Hemelsoet D, Vandermeeren Y, et al. The combined impact of dependency on caregivers, disability, and coping strategy on quality of life after ischemic stroke. Health Qual Life Outcomes. 2019;17(1):31.CrossRef
4.
Lamberti N, Straudi S, Malagoni AM, Argiro M, Felisatti M, Nardini E, et al. Effects of low-intensity endurance and resistance training on mobility in chronic stroke survivors: a pilot randomized controlled study. Eur J Phys Rehabil Med. 2017;53(2):228–39.PubMed
5.
Kim H, Yoo EY, Jung MY, Kim J, Park JH, Kang DH. The effects of mental practice combined with modified constraint-induced therapy on corticospinal excitability, movement quality, function, and activities of daily living in persons with stroke. Disabil Rehabil. 2018;40(20):2449–57.CrossRef
6.
Nouwens F, Visch-Brink EG, Van de Sandt-Koenderman MME, Dippel DWJ, Koudstaal PJ, de Lau LML. Optimal timing of speech and language therapy for aphasia after stroke: more evidence needed. Expert Rev Neurother. 2015;15(8):885–93.CrossRef
7.
Marei HE, Hasan A, Rizzi R, Althani A, Afifi N, Cenciarelli C, et al. Potential of stem cell-based therapy for ischemic stroke. Front Neurol. 2018;9:34.CrossRef
8.
Chavez LM, Huang S-S, MacDonald I, Lin J-G, Lee Y-C, Chen Y-H. Mechanisms of acupuncture therapy in ischemic stroke rehabilitation: a literature review of basic studies. Int J Mol Sci. 2017;18(11):2270.CrossRef
9.
Yang YJ, Zhang J, Hou Y, Jiang BY, Pan HF, Wang J, et al. Effectiveness and safety of Chinese massage therapy (Tui Na) on post-stroke spasticity: a prospective multicenter randomized controlled trial. Clin Rehabil. 2017;31(7):904–12.CrossRef
10.
Han SY, Hong ZY, Xie YH, Zhao Y, Xu X. Therapeutic effect of Chinese herbal medicines for post stroke recovery: a traditional and network meta-analysis. Medicine. 2017;96(49):13.
11.
Xu HY, Shi Y, Zhang YQ, Jia Q, Li DF, Zhang Y, et al. Identification of key active constituents of Buchang Naoxintong capsules with therapeutic effects against ischemic stroke by using an integrative pharmacology-based approach. Mol BioSyst. 2016;12(1):233–45.CrossRef
12.
Mu QC, Liu PF, Hu XT, Gao HJ, Zheng X, Huang HY. Neuroprotective effects of Buyang Huanwu decoction on cerebral ischemia-induced neuronal damage. Neural Regeneration Research. 2014;9(17):1621–7.CrossRef
13.
Liao JZ, Li CY, Huang J, Liu WP, Chen HC, Liao SY, et al. Structure characterization of honey-processed astragalus polysaccharides and its anti-inflammatory activity in vitro. Molecules. 2018;23(1):11.CrossRef
14.
Huang YF, Lu L, Zhu DJ, Wang M, Yin Y, Chen DX, et al. Effects of astragalus polysaccharides on dysfunction of mitochondrial dynamics induced by oxidative stress. Oxid Med Cell Longev. 2016;2016:9573291.PubMedPubMedCentral
15.
Zhang LM, Wang HS, Wang T, Jiang N, Yu PF, Chong YT, et al. Ferulic acid ameliorates nerve injury induced by cerebral ischemia in rats. Exp Therap Med. 2015;9(3):972–6.CrossRef
16.
Lin CM, Chiu JH, Wu IH, Wang BW, Pan CM, Chen YH. Ferulic acid augments angiogenesis via VEGF, PDGF and HIF-1 alpha. J Nutr Biochem. 2010;21(7):627–33.CrossRef
17.
Wang L, Jiang DM. Neuroprotective effect of Buyang Huanwu Decoction on spinal ischemia-reperfusion injury in rats is linked with inhibition of cyclin-dependent kinase 5. BMC Complement Altern Med. 2013;13:309.CrossRef
18.
Pan RH, Cai J, Zhan LC, Guo YH, Huang RY, Li X, et al. Buyang Huanwu decoction facilitates neurorehabilitation through an improvement of synaptic plasticity in cerebral ischemic rats. BMC Complement Altern Med. 2017;17:11.CrossRef
19.
Hao C, Wu F, Shen J, Lu L, Fu D-L, Liao W-J, et al. Clinical efficacy and safety of buyang huanwu decoction for acute ischemic stroke: a systematic review and meta-analysis of 19 randomized controlled trials. Evidence-based complementary and alternative medicine : eCAM. 2012:630124-.
20.
Gou Y, Wu J, Mo X, Tain L. A meta-analysis of a randomized controlled trial of buyang huanwu decoction combined with acupuncture and buyang huanwu decoction alone in the treatment of stroke hemiplegia. Asia-Pacific Trad Med. 2019;15(1):153–6.
21.
Han CH, Kim M, Cho SY, Jung WS, Moon SK, Park JM, et al. Adjunctive herbal medicine treatment for patients with acute ischemic stroke: A systematic review and meta-analysis. Complement Ther Clin Pract. 2018;33:124–37.CrossRef
22.
23.
Chang L, Wang Y. Treatment of 100 Cases of cerebral infarction with modified Buyang Huanwu decoction. China’s Naturopathy. 2014;22(10):49–50.
24.
Cui H, Zhang P. Clinical study on treatment of 72 cases of apoplexy sequel with Tongnao decoction. J Clin Med Lit. 2016;3(47):9434–5.
25.
Jian S, Feng F. Therapeutic effect of Jiawei Buyang Huanwu Decoction on the recovery of ischemic stroke. Jilin J Trad Chin Med. 2006;26(11):15.
26.
Li S, Chen S. Ultimately also five soup treating stroke hemiplegia random parallel control study. J Pract Trad Chin Internal Med. 2013;27(11):21–2.
27.
Li S. The application of Buyang Huanwu decoction in the sequelae of stroke. Chin Med Mod Dist Educ China. 2016;14(5):61–2.
28.
Luo K. Analysis of clinical efficacy of traditional Chinese medicine in treating sequelae of ischemic stroke. Yiayao Qianyan. 2016;6(5):342–3.
29.
Xu S. Clinical observation of squeal of apoplexy with Buyang Huanwu decoction. Chin J Ethnomed Ethnopharm. 2015;12:48–9.
30.
Yan Y. Clinical observation on the treatment of apoplexy of Qi deficiency and blood stasis syndrome with Sanqi Buyang Huanwu decoction. Yiayao Qianyan. 2015;5(33):339–40.
31.
Ying W. Quantianlong Buyanghuanwu Tang treated stroke hemiplegia randomized controlled study. J Pract Trad Chin Internal Med. 2016;30(10):27–9.
32.
Zhang D. Clinical observation on the treatment of the sequela of stroke with Qi deficiency and blood stasis type by modified Buyang Huanwu decoction. Nei Mongol J Trad Chin Med. 2013;32(21):88.
33.
Zhang H, Liu W, Ceng J. Clinical observation of Peiyuan Tongnao capsule in treating cerebral infarction. Cardiovasc Dis J Integr Trad Chin Western Med. 2018;6(1):45–6.
Metadata
Title
Effect of Buyang Huanwu decoction for the rehabilitation of ischemic stroke patients: a meta-analysis of randomized controlled trials
Authors
Li Gao
Zhuoran Xiao
Chunhua Jia
Wei Wang
Publication date
01-12-2021
Publisher
BioMed Central
Keyword
Stroke
Published in
Health and Quality of Life Outcomes / Issue 1/2021
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-021-01728-6

Other articles of this Issue 1/2021

Health and Quality of Life Outcomes 1/2021 Go to the issue

Research

Translation and cross-cultural adaption of the Chinese version of the Vanderbilt Head and Neck Symptom Survey version 2.0: a tool for oral symptom assessment in head and neck cancer patients

Research

Attachment: the mediating role of hope, religiosity, and life satisfaction in older adults

Research

Mental and physical health, and long-term quality of life among service members injured on deployment

Research

The role of antimicrobial resistance on long-term mortality and quality of life in critically ill patients: a prospective longitudinal 2-year study

Research

Validation of the WHOQOL-Bref: psychometric properties and normative data for the Norwegian general population

Research

Factor structure and psychometric properties of a Polish adaptation of the Warwick–Edinburgh Mental Wellbeing Scale